TrialSite reminds the community of clinical trials professionals of the importance of Clinical Trials Transformation Initiative (CTTI), co-founded by the U.S. Food and Drug Administration (FDA) and Duke University to identify and promote practices that increase clinical trials quality and efficiency. CTTI brings evidence-based work to practice, informing the ongoing improvement of clinical research.
Please join CTTI tomorrow, Oct. 5 at noon ET for a public webinar on "Next Steps for Obtaining Novel Endpoint Reliability & Acceptance" – the third in a series of webinars on using novel digitally derived endpoints in clinical trials for medical product development from the Clinical Trials Transformation Initiative (CTTI), Digital Medicine Society (DiMe), and TransCelerate.
Presenters Lindsay Kehoe, CTTI, and Alicia Staley, Medidata, will discuss CTTI's current work to obtain reliability and acceptance of meaningful, digitally derived novel endpoints – a project that builds on its existing novel endpoint development of recommendations and resources from 2017.
Attendees will hear:
Highlights from a recent Expert Meeting of leaders and stakeh...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).